Inflammatory Liver Tumor Caused by

Fasciola hepatica Inflammatory liver tumor intrahepatic cholangiocarcinoma

Journal

Anticancer research
ISSN: 1791-7530
Titre abrégé: Anticancer Res
Pays: Greece
ID NLM: 8102988

Informations de publication

Date de publication:
May 2020
Historique:
received: 09 03 2020
revised: 01 04 2020
accepted: 02 04 2020
entrez: 6 5 2020
pubmed: 6 5 2020
medline: 4 6 2020
Statut: ppublish

Résumé

Human fascioliasis is a rare parasitic disease outside of countries in which it is endemic. The diagnosis of hepatic-phase fascioliasis by diagnostic imaging alone is challenging. A 69-year-old female was referred to our hospital for the treatment of a solitary solid cystic mass lesion, 6 cm in diameter, accompanied with mild symptoms and minimal changes in laboratory parameters. Intrahepatic cholangiocarcinoma was suspected, and she underwent extended posterior sectionectomy. Four months later, she was re-admitted because of fatigue, high fever, and epigastric pain. Her eosinophil fraction and immunoglobulin E levels were extremely elevated (49.1% and 6833 IU/ml, respectively). She was found to have two new reticular cystic hepatic tumors. Serum dot enzyme-linked immunosorbent assay for parasites revealed strong positivity for Fasciola hepatica. Praziquantel was ineffective, and multi-cystic tumors rapidly developed in the left lateral section, requiring emergency left lateral sectionectomy. An F. hepatica helminth, approximately 3 cm in size, was observed on the cut liver surface during hepatic resection. Prophylactic triclabendazole (1,000 mg/day) was administered twice. She has been well for over 10 years without relapse of fascioliasis. In patients with hepatic tumors accompanied by inflammatory changes and eosinophilia, detailed medical history and serological testing by dot enzyme-linked immunosorbent assay for parasites are strongly recommended.

Identifiants

pubmed: 32366426
pii: 40/5/2795
doi: 10.21873/anticanres.14252
doi:

Types de publication

Case Reports Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

2795-2800

Informations de copyright

Copyright© 2020, International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved.

Auteurs

Takayoshi Kaida (T)

Department of Surgery, Miyazaki Nobeoka Prefectural Hospital, Nobeoka, Japan.

Toru Beppu (T)

Department of Surgery, Yamaga City Medical Center, Yamaga, Japan tbeppu@yamaga-mc.jp.

Hiromitsu Hayashi (H)

Department of Gastroenterological Surgery, Graduate School of Life Sciences, Kumamoto University, Kumamoto, Japan.

Katsunori Imai (K)

Department of Gastroenterological Surgery, Graduate School of Life Sciences, Kumamoto University, Kumamoto, Japan.

Kensuke Yamamura (K)

Department of Gastroenterological Surgery, Graduate School of Life Sciences, Kumamoto University, Kumamoto, Japan.

Hirohisa Okabe (H)

Department of Gastroenterological Surgery, Graduate School of Life Sciences, Kumamoto University, Kumamoto, Japan.

Kazuki Matsumura (K)

Department of Gastroenterological Surgery, Graduate School of Life Sciences, Kumamoto University, Kumamoto, Japan.

Daiki Yoshii (D)

Department of Cell Pathology, Graduate School of Life Sciences, Kumamoto University, Kumamoto, Japan.

Yoshihiro Komohara (Y)

Department of Cell Pathology, Graduate School of Life Sciences, Kumamoto University, Kumamoto, Japan.

Shinichi Akahoshi (S)

Department of Surgery, Yamaga City Medical Center, Yamaga, Japan.

Koichi Doi (K)

Department of Surgery, Miyazaki Nobeoka Prefectural Hospital, Nobeoka, Japan.

Yo-Ichi Yamashita (YI)

Department of Gastroenterological Surgery, Graduate School of Life Sciences, Kumamoto University, Kumamoto, Japan.

Hideo Baba (H)

Department of Gastroenterological Surgery, Graduate School of Life Sciences, Kumamoto University, Kumamoto, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH